Companies / OnKure Therapeutics, Inc. / Activity
Activity — OnKure Therapeutics, Inc.
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Manke Isaac Director | Grant | Class A Common Stock | $0 | +5K +34.31% | 20,583 0.05% of shares | low |
| Dec 31, 2025 | Mathers Edward T Director | Grant | Class A Common Stock | $0 | +4K +34.31% | 15,310 0.04% of shares | low |
| Mar 23, 2026 | Saccomano Nicholas A CEO | Sell | Class A Common Stock | $357 | -86 -1.16% | 7,333 0.02% of shares | low |
| Mar 23, 2026 | Leverone Jason A. Executive | Sell | Class A Common Stock | $1.3K | -301 -1.85% | 16,000 0.04% of shares | low |
| Jun 4, 2026 | Mathers Edward T Director | Grant | Stock Option (right to buy) | — | +8K | 7,650 0.02% of shares | low |
| Jun 4, 2026 | Grey Michael G Director | Grant | Stock Option (right to buy) | — | +8K | 7,650 0.02% of shares | low |